Lario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research
July 22, 2024
Edinburgh, UK, 22 July 2024: Lario Therapeutics (‘Lario’, or ‘the Company’), a biopharmaceutical company developing first-in-class precision medicines for epileptic and neurological disorders, today announced